Oncology & Cancer

RNA mystery solved in triple negative breast cancer

Researchers at Thomas Jefferson University have discovered why conventional efforts to block a tiny strand of ribonucleic acid, called microRNA, in triple negative breast cancer cells failed. In a study published December ...

Oncology & Cancer

Patterns found in cancer's chaos illuminate tumor evolution

For more than 100 years, researchers have been unable to explain why cancer cells contain abnormal numbers of chromosomes, a phenomenon known as aneuploidy. Many believed aneuploidy was simply a random byproduct of cancer.

Oncology & Cancer

Epigenetic analysis of aggressive brain tumors

Glioblastoma is a highly aggressive brain cancer that predominantly affects people in their 50s, 60s and 70s. Even under the best available care, half of the patients die within one year after diagnosis, and very few live ...

Oncology & Cancer

Study points to potential new lung cancer therapy

New findings about regulation of PD-L1, a protein that allows cancer to evade the immune system, has shown therapeutic promise for several cancers, including the most common form of lung cancer.

Oncology & Cancer

Waking up dormant tumour suppressor genes

A drug-free cancer treatment could teach our genes to destroy the disease from within, according to Western Australian medical researchers.

page 13 from 36